In vivo CAMPATH-1 monoclonal antibodies: A novel mode of therapy for acute graft-versus-host disease [4]

American Journal of Hematology

Volumn 52, Issue 3, 1996, Pages 236-237

  Varadi, G ^a   Or, R ^a   Slavin, S ^a   Nagler, A ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTINEOPLASTIC AGENT; ANTIPYRETIC AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; CANCER PATIENT; CASE REPORT; CHILL; CHRONIC MYELOID LEUKEMIA; FEMALE; FEVER; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LETTER; PRIORITY JOURNAL; SKIN MANIFESTATION; TREATMENT OUTCOME;

ACUTE DISEASE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; GRAFT VS HOST DISEASE; HUMANS; RATS;

EID: 0029680801     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199607)52:3<236::AID-AJH23>3.0.CO;2-C     Document Type: Letter

References (0)